Patents by Inventor Joanne York

Joanne York has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immuno-reactive peptide CTL epitopes of human cytomegalovirus
    Patent number: 6251399
    Abstract: The invention provides a plurality of peptides (and immunologically functional variants thereof) which are immunogenic epitopes recognized by CD8+ class I MHC restricted cytotoxic T-lymphocytes of patients harboring latent cytomegalovirus (HCMV) infection. The peptides are capable of activating CTLs and CTLp's in the absence of active viral replication, and thus are useful for eliciting a cellular immune response against HCMV by normal and immunodeficient subjects. Polypeptide and lipopeptide vaccines, with and without adjuvants, also are disclosed.
    Type: Grant
    Filed: March 27, 2000
    Date of Patent: June 26, 2001
    Inventors: Don Jeffrey Diamond, Joanne York
  • Immuno-reactive peptide CTL epitopes of human cytomegalovirus
    Patent number: 6156317
    Abstract: The invention provides a plurality of peptides (and immunologically functional variants thereof) which are immunogenic epitopes recognized by CD8.sup.+ class I MHC restricted cytotoxic T-lymphocytes of patients harboring latent cytomegalovirus (HCMV) infection. The peptides are capable of activating CTLs and CTLp's in the absence of active viral replication, and thus are useful for eliciting a cellular immune response against HCMV by normal and immunodeficient subjects. Polypeptide and lipopeptide vaccines, with and without adjuvants, also are disclosed.
    Type: Grant
    Filed: February 10, 1998
    Date of Patent: December 5, 2000
    Assignee: City of Hope
    Inventors: Don Jeffrey Diamond, Joanne York
  • Immuno-reactive peptide CTL epitopes of human cytomegalovirus
    Patent number: 6074645
    Abstract: The invention provides a plurality of peptides (and immunologically functional variants thereof) which are immunogenic epitopes recognized by CD8.sup.+ class I MHC restricted cytotoxic T-lymphocytes of patients harboring latent cytomegalovirus (HCMV) infection. The peptides are capable of activating CTLs and CTLp's in the absence of active viral replication, and thus are useful for eliciting a cellular immune response against HCMV by normal and immunodeficient subjects. Polypeptide and lipopeptide vaccines, with and without adjuvants, also are disclosed.
    Type: Grant
    Filed: May 11, 1998
    Date of Patent: June 13, 2000
    Assignee: City of Hope
    Inventors: Don Jeffrey Diamond, Joanne York